WCN25-1664 Epidemiology, disease burden and treatment patterns for primary IgA nephropathy patients: A real-world data study in The Netherlands

58%) were from the most deprived areas, and 57 (28%) were from middle-range areas.Conclusions: This study highlights significant gaps in lipid management among pre-dialysis CKD patients, with a notable disparity affecting those from socioeconomically deprived areas.Despite established guidelines, a considerable number of patients remain untreated or inadequately controlled for dyslipidemia, increasing their risk for cardiovascular events.These findings underscore the urgent need for targeted interventions and more equitable healthcare strategies to enhance lipid control, particularly in vulnerable populations.Regular monitoring and appropriate use of LLT are essential steps in reducing CVD risk and improving outcomes for CKD patients.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Authors

Institutions

Publication Details

Journal
Kidney International Reports
Published
2025-01-27
DOI
https://doi.org/10.1016/j.ekir.2024.11.538
Citations
1
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
1.43
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

WCN25-1664 Epidemiology, disease burden and treatment patterns for primary IgA nephropathy patients: A real-world data study in The Netherlands

Thom S. Lysen, Alice Eberhardt, Brenda N. Baak, Hema K. Gandhi et al.
1 citations
Kidney International Reports
Renal Diseases and Glomerulopathies
1.43
article

WCN25-1664 Epidemiology, disease burden and treatment patterns for primary IgA nephropathy patients: A real-world data study in The Netherlands

Thom S. Lysen, Alice Eberhardt, Brenda N. Baak, Hema K. Gandhi, Sasikiran Nunna, Raphaël Duivenvoorden, Jetty A. Overbeek, Naomi Reines, Lisa Smitts
article en
1 citations

Abstract

58%) were from the most deprived areas, and 57 (28%) were from middle-range areas.Conclusions: This study highlights significant gaps in lipid management among pre-dialysis CKD patients, with a notable disparity affecting those from socioeconomically deprived areas.Despite established guidelines, a considerable number of patients remain untreated or inadequately controlled for dyslipidemia, increasing their risk for cardiovascular events.These findings underscore the urgent need for targeted interventions and more equitable healthcare strategies to enhance lipid control, particularly in vulnerable populations.Regular monitoring and appropriate use of LLT are essential steps in reducing CVD risk and improving outcomes for CKD patients.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Kidney International ReportsVol. 10(2)
Radboud University Nijmegen (NL), Radboud University Medical Center (NL), Otsuka (United States) (US), Pharmo Institute (NL), Otsuka Pharmaceutical (Spain) (ES)
Good health and well-being
Openalex Percentile: Top 23%
Renal Diseases and Glomerulopathies
1.43
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.